Peritonitis in recent years: Clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1529-1537

  Oliveira, Luiz Gustavo ^a   Luengo, Juliana ^a   Caramori, Jacqueline C T ^a   Montelli, Augusto C ^a   Cunha, Maria De Lourdes R S ^a   Barretti, Pasqual ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Clinical findings; Etiology; Outcome; Peritoneal dialysis; Peritonitis; Treatment

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; GENTAMICIN; METICILLIN; OXACILLIN; PSEUDOMONIC ACID; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRAZIL; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEMOGRAPHY; ENTEROBACTERIACEAE; FEMALE; FERMENTATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; OUTCOME ASSESSMENT; PENICILLIN RESISTANCE; PERITONEAL DIALYSIS; PERITONITIS; PREDICTIVE VALIDITY; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE;

AGE FACTORS; AGED; AMIKACIN; ANTI-BACTERIAL AGENTS; BRAZIL; CEFAZOLIN; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOCCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXACILLIN; PERITONEAL DIALYSIS; PERITONITIS; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84867870899     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0107-7     Document Type: Article

References (26)

1. Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002-2003. Perit Dial Int 29:297-302
2. Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F (2005) Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 25:274-284
3. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P (2011) Geographic and educational factors and risk of the first peritonitis episode in Brazilian peritoneal dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 8:1944-1951
4. Silva B, Hawley CM, McDonald SP, Brown FC, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 4:957-964
5. Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PKT (2008) Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3:91-97
6. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393-423
7. Piraino B, Bernardini J, Florio T, Fried L (2003) Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 23:456-459
8. Bender FH, Bernardini J, Piraino B (2006) Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 103:S44-S54
9. Prasad N, Gupta A, Sharma RK, Prasad KN, Gulati S, Sharma AP (2003) The spectrum of bacterial peritonitis in CAPD patients in a developing country: is it different? Perit Dial Int 23:400-402
10. Barretti P, Bastos KA, Dominguez J, Caramori JC (2007) Peritonitis in Latin América. Perit Dial Int 27:332-339
11. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW (2004) Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 24:424-432
12. Barretti P, Pereira D, Brasil MA, de Lourdes Cunha M, Caramori J, Montelli A (2009) Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center's experience over nine years. Perit Dial Int 29:230-233
13. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B (2005) Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16:539-545
14. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S (2000) Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20: 396-411
15. Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA (1999) Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34:14-20
16. Baker RJ, Senior H, Clemenger M, Brown EA (2003) Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 41:670-675
17. Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK (2005) Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 68: 2375-2380
18. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F (2005) Uttley L; ISPD Ad Hoc Advisory Committee. Peritoneal dialysisrelated infections recommendations: 2005 update. Perit Dial Int 25:107-131
19. Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18, 18th edn. CLSI, Wayne
20. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, Donker AJ (1994) Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120:264-271
21. Sanchez AR, Madonia C, Rascon-Pacheco RA (2008) Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Kidney Int Suppl 108:S76-S80
22. Oo TN, Roberts TL, Collins AJ (2005) A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 45:372-380
23. Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 4:1195-1200
24. Voinescu CG, Khanna R (2002) Peritonitis in peritoneal dialysis. Int J Artif Organs 25:249-260
25. Lim W, Dogra G, McDonald SP, Brown FG, Johnson DW (2011) Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitisrelated mortality. Perit Dial Int. [Epub ahead of print]
26. Wiggins KJ, Johnson DW, Craig JC, Strippoli GF (2007) Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. Am J Kidney Dis 50:967-988